BR Biopharma (NASDAQ:BRBI) Shares Down 0.9% – Here’s Why

BR Biopharma, Inc. (NASDAQ:BRBI) shares fell 0.9% on Wednesday . The company traded as low as $11.67 and last traded at $11.6490. 2,955 shares were traded during mid-day trading, an increase of 141% from the average session volume of 1,225 shares. The stock had previously closed at $11.75.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

BR Biopharma Stock Performance

The company has a fifty day moving average of $14.17.

BR Biopharma (NASDAQ:BRBI) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $0.09 earnings per share for the quarter. The business had revenue of $25.95 million during the quarter.

BR Biopharma Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 5th. Investors of record on Tuesday, May 19th were paid a $0.147 dividend. This represents a $0.59 annualized dividend and a dividend yield of 5.0%. The ex-dividend date of this dividend was Tuesday, May 19th.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in BR Biopharma stock. Acuitas Investments LLC bought a new position in BR Biopharma, Inc. (NASDAQ:BRBI) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma accounts for about 3.2% of Acuitas Investments LLC’s holdings, making the stock its 7th biggest position.

About BR Biopharma

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.